文献速递心外重症与机械循环支持

左心室辅助装置候选者伴右心室功能障碍的临时机械循环支持:早期高危但非长期无用

Temporary mechanical circulatory support in left ventricular assist device candidates with right ventricular dysfunction: Acuity without long-term futility.
PubMed 文献 · J Heart Lung Transplant · 2026-03-20

该多中心回顾性队列研究纳入2018至2022年接受HeartMate 3植入的201例客观定义右心室功能障碍的成人患者,按术前是否使用临时机械循环支持(tMCS)分组。tMCS组早期并发症更多、1年和2年生存率更低,但3年生存率及30至180天后的条件生存率两组相似。比例风险分析显示tMCS独立关联早期而非长期死亡风险。

要点

  • tMCS仅关联早期死亡风险增加,不增加长期死亡风险
  • 条件生存超过30至180天后两组生存率相似
  • 不应将tMCS使用视为LVAD无用的证据

核心结论

  • 在客观定义右心室功能障碍的LVAD接受者中,术前tMCS识别早期围术期高风险患者,但不赋予条件生存者长期死亡风险。

研究设计与样本

  • 多中心回顾性队列研究,纳入201例2018至2022年接受HeartMate 3植入且客观定义右心室功能障碍的成人患者。

主要发现

  • tMCS组INTERMACS和EUROMACS-RHF评分更高、血流动力学代偿更严重且通气支持更多。
  • tMCS组早期并发症增加,包括ICU停留和机械通气延长及RVAD使用率更高。
  • tMCS组1年和2年生存率更低,但3年生存率及30至180天后的条件生存率两组相似。
  • 比例风险分析显示tMCS独立关联早期而非长期死亡风险。

关键数值与推荐

  • 右心室功能障碍定义:超声心动图TAPSE<16 mm和/或定性右心室功能障碍,且侵入性血流动力学CVP/PCWP>0.54和/或PAPi<2.0伴心脏指数<2.2 L/min/m²。

临床怎么用

  • 术前tMCS应视为早期围术期风险标志,而非LVAD长期无用的依据。
  • 对tMCS后存活超过30至180天的患者,长期预后与未用tMCS者相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Temporary mechanical circulatory support (tMCS) is increasingly used as a bridge to durable left ventricular assist device (LVAD) implantation in patients with advanced heart failure, particularly those with right ventricular dysfunction (RVD). RVD at the time of LVAD implantation predicts early morbidity and mortality, and preoperative tMCS has been associated with inferior survival in registry analyses. However, whether tMCS independently contributes to long-term risk or simply identifies high-acuity patients remains unclear. METHODS: We conducted a retrospective, multicenter cohort study of 201 adult patients with objectively defined RVD undergoing HeartMate 3 implantation between 2018 and 2022. RVD was confirmed by echocardiography (TAPSE <16 mm and/or qualitative RV dysfunction) and invasive hemodynamics (CVP/PCWP >0.54 and/or PAPi <2.0 with cardiac index <2.2L/min/m²). Patients were stratified by preoperative tMCS use. Outcomes included early postoperative morbidity, survival at 1 to 3 years, and conditional survival after 30-, 90-, and 180-days. RESULTS: tMCS patients had higher INTERMACS and EUROMACS-RHF scores, more severe hemodynamic compromise, and greater ventilatory support. They experienced increased early morbidity, including prolonged ICU stay, mechanical ventilation, and higher RVAD utilization. One- and 2-year survival was lower in tMCS patients, but 3-year survival and conditional survival beyond 30 to 180 days were similar between groups. Proportional hazards analysis showed that tMCS was independently associated with earlier but not longer-term mortality. CONCLUSIONS: In LVAD recipients with defined RVD, preoperative tMCS identifies patients at heightened early perioperative risk but does not confer durable mortality risk among conditional survivors. These findings underscore the importance of separating early procedural hazard from durable prognosis and caution against interpreting tMCS use as evidence of LVAD futility.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Crespo-Diaz R, Hryniewicz K, Samara M, et al. Temporary mechanical circulatory support in left ventricular assist device candidates with right ventricular dysfunction: Acuity without long-term futility. J Heart Lung Transplant. 2026. PMID: 41865849. doi:10.1016/j.healun.2026.02.1683

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。